Clinical Trial Update: Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for glioma using adaptive radiotherapy guided by an artificial intelligence workflow; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Glioma
• Glioblastoma

Snippet

Sponsor: Tata Memorial Centre | Conditions: Diffuse Glioma, Glioblastoma | Phase 2 | Status: NOT_YET_RECRUITING